Literature DB >> 9531159

Role of T cells in atopic dermatitis. New aspects on the dynamics of cytokine production and the contribution of bacterial superantigens.

U Herz1, R Bunikowski, H Renz.   

Abstract

Atopic dermatitis (AD) is a chronically relapsing inflammatory skin disease. Influx of activated T cells into the skin lesions represents a hallmark in AD. Recent results indicate a dynamic T-cell-derived cytokine production in AD. In addition to the well-known TH-2 component, chronic lesions and late-phase allergic responses are characterized by an TH-1/TH-0 cytokine pattern. Although there is no doubt that aeroallergens can contribute to the elicitation of acute- and late-phase allergic responses in AD, their role in the immunopathogenesis is controversally discussed. Recent attention has been given to the long-known phenomenon of persistent colonization of AD skin with S. aureus and the potential role of S. aureus-derived superantigens. Evidence from several in vitro and in vivo studies suggests that such bacterial superantigens have the potency to trigger chronic T-cell-mediated skin inflammation. Although these data are certainly suggestive, further clinical studies are required to elucidate the role of bacterial superantigens in initiation, maintenance and, especially, chronicity of skin inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531159     DOI: 10.1159/000023899

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  18 in total

1.  T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis.

Authors:  A Trautmann; M Akdis; D Kleemann; F Altznauer; H U Simon; T Graeve; M Noll; E B Bröcker; K Blaser; C A Akdis
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  [Atopic dermatitis and psychological stress].

Authors:  U Raap; T Werfel; B Jaeger; G Schmid-Ott
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

Review 3.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

4.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

Authors:  J M Spergel; E Mizoguchi; H Oettgen; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease.

Authors:  Sergei I Ochkur; John Dongil Kim; Cheryl A Protheroe; Dana Colbert; Redwan Moqbel; Paige Lacy; James J Lee; Nancy A Lee
Journal:  J Immunol Methods       Date:  2011-10-12       Impact factor: 2.303

6.  Production of antibodies to staphylococcal superantigens in atopic dermatitis.

Authors:  D E Campbell; A S Kemp
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

7.  A biofabricated vascularized skin model of atopic dermatitis for preclinical studies.

Authors:  Xue Liu; Sam Michael; Kapil Bharti; Marc Ferrer; Min Jae Song
Journal:  Biofabrication       Date:  2020-04-09       Impact factor: 9.954

8.  Linkage of atopic dermatitis to chromosomes 4q22, 3p24 and 3q21.

Authors:  Ulla Christensen; Steffen Møller-Larsen; Mette Nyegaard; Annette Haagerup; Anne Hedemand; Charlotte Brasch-Andersen; Torben A Kruse; Thomas Juhl Corydon; Mette Deleuran; Anders D Børglum
Journal:  Hum Genet       Date:  2009-06-11       Impact factor: 4.132

Review 9.  Role of bacterial pathogens in atopic dermatitis.

Authors:  Yu-Tsan Lin; Chen-Ti Wang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

10.  Transgenic rat model of childhood-onset dermatitis by overexpressing telomerase reverse transcriptase (TERT).

Authors:  Ryosuke Kaneko; Atsuko Sato; Shun Hamada; Takeshi Yagi; Ichiro Ohsawa; Mamitaro Ohtsuki; Eiji Kobayashi; Masumi Hirabayashi; Takashi Murakami
Journal:  Transgenic Res       Date:  2016-02-17       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.